Philip Levin

Assistant Professor

1988 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Philip Levin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Type 2 Diabetes Mellitus Medicine & Life Sciences
Insulin Medicine & Life Sciences
Managed Care Programs Medicine & Life Sciences
Electronic Health Records Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Health Care Costs Medicine & Life Sciences
Hypoglycemic Agents Medicine & Life Sciences
Hypoglycemia Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1988 2019

Real-world evidence in diabetes: relevance to clinical practice

Blonde, L., Bailey, T., Strong, J. & Levin, P., Apr 1 2019, In : The Journal of family practice. 68, 3

Research output: Contribution to journalArticle

Randomized Controlled Trials
Patient Acceptance of Health Care
Safety
Health Resources
Health Care Costs

Predictors and clinical outcomes of treatment intensification in patients with type 2 diabetes uncontrolled on basal insulin in a real-world setting

Kallenbach, L., Shui, A. M., Cheng, W. Y., Fan, T., Hu, W., Zichlin, M. L., Duh, M. S., Ye, F. & Levin, P., Sep 1 2018, In : Endocrine Practice. 24, 9, p. 805-814 10 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Insulin
Injections
Odds Ratio
Confidence Intervals
Electronic Health Records
Type 2 Diabetes Mellitus
Meals
Retrospective Studies
Insulin

A real-world study of treatment patterns and outcomes in US managed-care patients with type 2 Diabetes initiating injectable therapies

Wei, W., Buysman, E., Grabner, M., Xie, L., Brekke, L., Ke, X., Chu, J. W. & Levin, P., Mar 1 2017, In : Diabetes, Obesity and Metabolism. 19, 3, p. 375-386 12 p.

Research output: Contribution to journalArticle

Managed Care Programs
Type 2 Diabetes Mellitus
Injections
Therapeutics
Health Care Costs
Short-Acting Insulin
Glucagon-Like Peptide 1
Health Care Costs
Type 2 Diabetes Mellitus
Insulin